Challenges and future directions of potential natural products leads against 2019-nCoV outbreak

Except for Remdesivir® no other drug or vaccine has yet been approved to treat the coronavirus disease (COVID-19) caused by the virus known as, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Remdesivir® an small molecule and nucleic acid analogue, it is used to treat adults and childr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ospanov, Meirambek, León, Francisco, Jenis, Janar, Khan, IKhlas A., Ibrahim, Mohamed A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543902/
https://www.ncbi.nlm.nih.gov/pubmed/33052305
http://dx.doi.org/10.1016/j.cpb.2020.100180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543902/
https://www.ncbi.nlm.nih.gov/pubmed/33052305
http://dx.doi.org/10.1016/j.cpb.2020.100180

Ejemplares similares